+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

AmpliPhi Biosciences Corp (APHB) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Biomx Ltd
  • EnBiotix Inc
  • EpiBiome Inc
  • Intralytix Inc
  • iNtRON Biotechnology Inc
  • Locus Biosciences Inc
  • MORE
AmpliPhi Biosciences Corp (APHB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

AmpliPhi Biosciences Corp (AmpliPhi) is a biotechnology company which focuses on development and commercialization of bacteriophage-based antibacterial therapeutics. The company by utilizing its proprietary bacteriophage technology developed a pipeline of products for the treatment of various antibiotic-resistant bacterial infections. Its pipeline product portfolio includes AB-SA01 for Staphylococcus aureus (S. aureus) infections including methicillin-resistant S. aureus and AB-PA01 for Pseudomonas aeruginosa lung infections in cystic fibrosis patients. It has manufacturing facility in Ljubljana, Slovenia; and a laboratory in Richmond, Virginia and Brookvale, Australia. AmpliPhi is headquartered in San Diego, California, the US.

AmpliPhi Biosciences Corp Key Recent Developments

Mar 14, 2018: AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2017 Financial Results and Business Highlights
Dec 14, 2017: AmpliPhi Biosciences Provides Corporate and Strategic Update
Nov 14, 2017: AmpliPhi Biosciences Reports Third Quarter 2017 Financial Results and Business Highlights
Sep 06, 2017: AmpliPhi Biosciences Announces Receipt of $2.0 Million R&D Tax Incentive
Aug 14, 2017: AmpliPhi Biosciences Reports Second Quarter 2017 Financial Results and Business Highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Biomx Ltd
  • EnBiotix Inc
  • EpiBiome Inc
  • Intralytix Inc
  • iNtRON Biotechnology Inc
  • Locus Biosciences Inc
  • MORE
Section 1 - About the Company
  • AmpliPhi Biosciences Corp - Key Facts
  • AmpliPhi Biosciences Corp - Key Employees
  • AmpliPhi Biosciences Corp - Key Employee Biographies
  • AmpliPhi Biosciences Corp - Major Products and Services
  • AmpliPhi Biosciences Corp - History
  • AmpliPhi Biosciences Corp - Company Statement
  • AmpliPhi Biosciences Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • AmpliPhi Biosciences Corp - Business Description
  • AmpliPhi Biosciences Corp - Corporate Strategy
  • AmpliPhi Biosciences Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • AmpliPhi Biosciences Corp - Strengths
  • AmpliPhi Biosciences Corp - Weaknesses
  • AmpliPhi Biosciences Corp - Opportunities
  • AmpliPhi Biosciences Corp - Threats
  • AmpliPhi Biosciences Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • AmpliPhi Biosciences Corp, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 14, 2018: AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2017 Financial Results and Business Highlights
  • Dec 14, 2017: AmpliPhi Biosciences Provides Corporate and Strategic Update
  • Nov 14, 2017: AmpliPhi Biosciences Reports Third Quarter 2017 Financial Results and Business Highlights
  • Sep 06, 2017: AmpliPhi Biosciences Announces Receipt of $2.0 Million R&D Tax Incentive
  • Sep 06, 2017: AmpliPhi Biosciences Announces Receipt of $2.0 Million R&D Tax Incentive
  • Aug 14, 2017: AmpliPhi Biosciences Reports Second Quarter 2017 Financial Results and Business Highlights
  • Jul 05, 2017: AmpliPhi Biosciences to Present at Bacteriophage Therapy Workshop Sponsored by the FDA and NIH
  • May 31, 2017: AmpliPhi Biosciences Appoints Paul C. Grint, M.D. as Chief Executive Officer
  • May 30, 2017: AmpliPhi Biosciences to Present at 7th Annual LD Micro Invitational Conference on June 6
  • May 15, 2017: AmpliPhi Biosciences Reports First Quarter 2017 Financial Results and Provides Business Highlights
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • AmpliPhi Biosciences Corp, Key Facts
  • AmpliPhi Biosciences Corp, Key Employees
  • AmpliPhi Biosciences Corp, Key Employee Biographies
  • AmpliPhi Biosciences Corp, Major Products and Services
  • AmpliPhi Biosciences Corp, History
  • AmpliPhi Biosciences Corp, Other Locations
  • AmpliPhi Biosciences Corp, Subsidiaries
  • AmpliPhi Biosciences Corp, Key Competitors
  • AmpliPhi Biosciences Corp, Ratios based on current share price
  • AmpliPhi Biosciences Corp, Annual Ratios
  • AmpliPhi Biosciences Corp, Annual Ratios
  • AmpliPhi Biosciences Corp, Interim Ratios
  • AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • AmpliPhi Biosciences Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • AmpliPhi Biosciences Corp, Performance Chart (2013 - 2017)
  • AmpliPhi Biosciences Corp, Ratio Charts
  • AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 3
  • Synthetic Genomics Inc
  • Phagelux Inc
  • LytPhage Inc
  • Locus Biosciences Inc
  • iNtRON Biotechnology Inc
  • Intralytix Inc
  • EpiBiome Inc
  • EnBiotix Inc
  • Biomx Ltd
Note: Product cover images may vary from those shown
Adroll
adroll